AU2012203023B2 - N-(hetero)aryl, 2- (hetero)aryl-substituted acetamides for use as Wnt signaling modulators - Google Patents

N-(hetero)aryl, 2- (hetero)aryl-substituted acetamides for use as Wnt signaling modulators

Info

Publication number
AU2012203023B2
AU2012203023B2 AU2012203023A AU2012203023A AU2012203023B2 AU 2012203023 B2 AU2012203023 B2 AU 2012203023B2 AU 2012203023 A AU2012203023 A AU 2012203023A AU 2012203023 A AU2012203023 A AU 2012203023A AU 2012203023 B2 AU2012203023 B2 AU 2012203023B2
Authority
AU
Australia
Prior art keywords
hetero
aryl
wnt signaling
signaling modulators
substituted acetamides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2012203023A
Other versions
AU2012203023C1 (en
AU2012203023A1 (en
Inventor
Dai Cheng
Wenqi Gao
Dong Han
Shifeng Pan
Guobao Zhang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2010221493A external-priority patent/AU2010221493C1/en
Application filed by Novartis AG filed Critical Novartis AG
Priority to AU2012203023A priority Critical patent/AU2012203023C1/en
Priority claimed from AU2012203023A external-priority patent/AU2012203023C1/en
Publication of AU2012203023A1 publication Critical patent/AU2012203023A1/en
Publication of AU2012203023B2 publication Critical patent/AU2012203023B2/en
Application granted granted Critical
Publication of AU2012203023C1 publication Critical patent/AU2012203023C1/en
Assigned to NOVARTIS AG reassignment NOVARTIS AG Request for Assignment Assignors: IRM LLC
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

AU2012203023A 2009-03-02 2012-05-23 N-(hetero)aryl, 2- (hetero)aryl-substituted acetamides for use as Wnt signaling modulators Active AU2012203023C1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2012203023A AU2012203023C1 (en) 2009-03-02 2012-05-23 N-(hetero)aryl, 2- (hetero)aryl-substituted acetamides for use as Wnt signaling modulators

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US61/156,599 2009-03-02
US61/245,187 2009-09-23
AU2010221493A AU2010221493C1 (en) 2009-03-02 2010-03-01 N- (hetero)aryl, 2- (hetero)aryl-substituted acetamides for use as Wnt signaling modulators
AU2012203023A AU2012203023C1 (en) 2009-03-02 2012-05-23 N-(hetero)aryl, 2- (hetero)aryl-substituted acetamides for use as Wnt signaling modulators

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
AU2010221493A Division AU2010221493C1 (en) 2009-03-02 2010-03-01 N- (hetero)aryl, 2- (hetero)aryl-substituted acetamides for use as Wnt signaling modulators

Publications (3)

Publication Number Publication Date
AU2012203023A1 AU2012203023A1 (en) 2012-06-14
AU2012203023B2 true AU2012203023B2 (en) 2012-11-22
AU2012203023C1 AU2012203023C1 (en) 2013-11-07

Family

ID=46642810

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2012203023A Active AU2012203023C1 (en) 2009-03-02 2012-05-23 N-(hetero)aryl, 2- (hetero)aryl-substituted acetamides for use as Wnt signaling modulators

Country Status (1)

Country Link
AU (1) AU2012203023C1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113956236B (en) * 2017-12-05 2023-01-06 中国医学科学院药物研究所 Phthalimide compound and application thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2847253B1 (en) * 2002-11-19 2007-05-18 Aventis Pharma Sa NOVEL DERIVATIVES OF PYRIDAZINONES AS MEDICAMENTS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM

Similar Documents

Publication Publication Date Title
HK1160464A1 (en) N-(hetero)aryl, 2-(hetero)aryl-substituted acetamides for use as wnt signaling modulators
SI2516433T1 (en) Substituted n-(1h-indazol-4-yl)imidazoš1, 2-aćpyridine-3- carboxamide compounds as cfms inhibitors
IL209556A0 (en) Wnt PROTEIN SIGNALLING INHIBITORS
HK1163661A1 (en) Heteroaryl derivatives as cftr modulators cftr
IL208068A0 (en) Bridged heterocycles as hiv integrase inhibitors
HK1158198A1 (en) Novel substituted sulfamide derivatives
PL2247576T3 (en) Inhibitors for brassinosteroid signalling
EP2271962A4 (en) High retardation-amplitude photoelastic modulator
GB0909441D0 (en) Novel indole derivatives
ZA201006623B (en) Indolinone compound
IL214110A0 (en) 2,3-diaryl-or heteroaryl-substituted 1,1,1-trifluoro-2-hydroxypropyl compounds
IL208873A0 (en) Novel n-(2-amino-phenyl)-acrylamides
IL208137A0 (en) (hetero-)aryl cyclohexane derivatives
HK1259248A1 (en) Novel 1,2-bis-sulfonamide derivatives as chemokine receptor modulators
EP2310214A4 (en) Sidewall features for tires
AU2012203023B2 (en) N-(hetero)aryl, 2- (hetero)aryl-substituted acetamides for use as Wnt signaling modulators
AU2008100998A4 (en) Signalling Specification
EP2246054A4 (en) Fentanyl-containing patch for external use
IL206612A0 (en) Novel imidazolinylmethyl aryl sulfonamides
GB0823420D0 (en) a2-Adrenoceptor ligands
GB0718359D0 (en) Process for preparing sulphonamides
UA17633S (en) CAKE PACKAGING
AU2009905953A0 (en) Amine modified clay sorbents
IT1391664B1 (en) LIFTING DEVICE FOR VEHICLES
IL215134A0 (en) Carrier modulating accelerometer